Esbjerg Central Hospital < Espoo < Essen 45145

Facettes :

List of bibliographic references indexed by Espoo

Number of relevant bibliographic references: 7.

Ident.	Authors (with country if any)	Title
000B04 (2009)	H. Nissinen [Finlande] ; M. Kuoppam Ki [Finlande] ; M. Leinonen [Suède] ; A. H. Schapira [Royaume-Uni]	Early versus delayed initiation of entacapone in levodopa‐treated patients with Parkinson’s disease: a long‐term, retrospective analysis
000D88 (2008)	Aki S. Havulinna [Finlande] ; Pentti J. Tienari [Finlande] ; Reijo J. Marttila [Finlande] ; Kirsti K. Martikainen [Finlande] ; Johan G. Eriksson [Finlande] ; Olli Taskinen [Finlande] ; Elena Moltchanova [Finlande] ; Marjatta Karvonen [Finlande]	Geographical variation of medicated parkinsonism in Finland during 1995 to 2000
001898 (2002)	Werner Poewe [Autriche] ; G. Deuschl ; A. Gordin [Finlande] ; E. Kultalahti [Finlande] ; M. Leinonen [Finlande]	Efficacy and safety of entacapone in Parkinson's disease patients with suboptimal Levodopa response: a 6‐month randomized placebo‐controlled double‐blind study in Germany and Austria (Celomen study)
001A00 (2001)	V. V. Myllyl ; E. Kultalahti [Finlande] ; H. Haapaniemi [Finlande] ; M. Leinonen [Finlande]	Twelve‐month safety of entacapone in patients with Parkinson’s disease
001C34 (2000)	J. Lyytinen [Finlande] ; S. Kaakkola [Finlande] ; A. Gordin [Finlande] ; E.-R Kultalahti [Finlande] ; H. Ter V Inen [Finlande]	Entacapone and selegiline with l-dopa in patients with Parkinson's disease: an interaction study
002432 (1994)	T. Ker Nen [Finlande] ; A. Gordin [Finlande] ; M. Karlsson [Finlande] ; K. Korpela [Finlande] ; J. Pentik Inen [Finlande] ; H. Rita [Finlande] ; E. Schultz [Finlande] ; L. Sepp L [Finlande] ; T. Wikberg [Finlande]	Inhibition of soluble catechol- O -methyltransferase and single-dose pharmacokinetics after oral and intravenous administration of entacapone
002A04 (1985)	S. Kaakkola [Finlande] ; P. T. M Nnistö [Finlande] ; E. Nissinen [Finlande] ; A. Vuorela [Finlande] ; R. M Ntyl [Finlande]	The effect of an increased ratio of carbidopa to levodopa on the pharmacokinetics of levodopa

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AffRegInc.i -k "Espoo" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AffRegInc.i  \
                -Sk "Espoo" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AffRegInc.i
   |clé=    Espoo
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024